X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB Share Price   (REDY)

Here is the latest stock price and chart of Dr. Reddys. For more details, see the Dr. Reddys company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Dec 12, 2017 (Close)
Price (Rs)2,255.60 Open (Rs) 2,306.00 High (Rs) 2,328.00 Low (Rs) 2,235.90
% Change2.83 Volume 120,634 Value (Rs) 274,423,864 52-Week H/L 3,203.95 / 1,901.65
Live NSE Quotes Dec 12, 2017 (Close)
Price (Rs)2,256.35 Open (Rs) 2,324.50 High (Rs) 2,326.40 Low (Rs) 2,233.80
% Change2.89 Volume 1,482,214 Value (Rs) 3,372,133,613 52-Week H/L 3,203.85 / 1,901.15
Valuation
EPS (Rs)* 72.53 P/E Ratio (x) 31.10 Market Cap (Rs m) 373,775.48 P/BV (x) 3.05
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Dr. Reddys Share Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new


Today's Market

Indian Indices Fall, UN Raises GDP Forecast and Top Stocks in Action(Pre-Open)

On Tuesday, share markets in India opened in red and ended on a weak note. The BSE Sensex closed lower by 228 points to end at 33,227 while the broader NSE Nifty ended the day lower by 82 points.

Related Views On News

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Dine with Ivanka; Waltz with Salman!(The Honest Truth)

Dec 1, 2017

A Saudi template to solve Indian government's tax deficit problem.

Using Deposits to Rescue Banks is a Bad Idea; It Needs to Be Nipped in the Bud(Vivek Kaul's Diary)

Dec 11, 2017

The Financial Resolution and Deposit Insurance(FRDI) Bill proposes to do just this.

If You're Not Looking for 'Excitement' but 'Big Returns' from Stocks, This Is for You(The 5 Minute Wrapup)

Dec 7, 2017

One does not have to necessarily invest only in 'exciting' stocks to become wealthy.

Beat Fund Managers at Their Own Game with These Stocks(Smart Contrarian)

Dec 6, 2017

The road to big investment gains passes through this universe.

IPOs Underperform Broad Market Indices(Chart Of The Day)

Nov 30, 2017

How did the IPOs perform in 2017 compared to broad market indices?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS